InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 21, 2022
InMed Pharmaceuticals Strengthens Its Commercial Leadership Team With The Appointment Of Vice President Of Sales And… Feb 15, 2022
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook Jan 5, 2022